Using activated to prepare a pharmaceutical composition for the treatment of AIDS T lymphocytes.

摘要

The invention concerns the use of activated T cells in a dose effective INTERVENED CELLULAR IMMUNITY AGAINST TRANSFERRING cells infected with the AIDS virus; A) THE activated T cells are specific for an epitope of AIDS VIRUS AND ARE histocompatible with the patient; YB) LYMPHOCYTES T ARE ABLE TO INTERVENE THE T cell immunity specific AIDS virus, as seen in the following tests: (I) A cytotoxicity assay which activated T cells ARE incubated with the target cells PATIENT radiolabelled iNFECTED WITH AIDS virus BEING RELEASED BRAND RADIOACTIVE SIGN lyse the cells infected objective; And (II) a challenge test MEASURING THE POSSIBILITY OF activated T cells to proliferate and / or produce a lymphokine in response to stimulation with an epitope of AIDS VIRUS IN VITRO TO PREPARE A pharmaceutical composition for the treatment of AIDS.